Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
alecsat (7 trials)
temozolomide (temodar) (1 trial)
Breast Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Pancreatic Neoplasms (Phase 1)
Prostatic Neoplasms (Phase 1)
Triple Negative Breast Neoplasms (Phase 2)
Trials (7 total)
Trial APIs (2 total)